Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688056 Beijing LabTech Instruments
- 37.68
- +1.27+3.49%
Market Closed Apr 24 15:00 CST
2.54BMarket Cap63.01P/E (TTM)
38.60High36.10Low25.24KlotVolume36.18Open36.41Pre Close94.86MTurnover3.74%Turnover Ratio64.97P/E (Static)67.45MShares39.6852wk High3.06P/B2.54BFloat Cap19.1852wk Low43.69Limit Up67.45MShs Float86.24Historical High29.13Limit Down6.87%Amplitude16.80Historical Low0.92Dividend TTM37.59Avg Price9.56KlotAsk2.44%Div YieldTTM100Lot Size14.46KlotBid
Beijing LabTech Instruments Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -20.27%256.03M | -38.98%288.55M | -8.64%329.7M | -17.36%320.5M | -17.27%321.14M | 26.84%472.91M | 3.49%360.9M | -21.83%387.84M | -17.28%388.17M | -24.61%372.84M |
| Transactional financial assets | 22.97%265.07M | 213.69%235.52M | -12.16%138.12M | 23.29%160.51M | 61.86%215.57M | -55.92%75.08M | -12.65%157.23M | 225.47%130.19M | 77.57%133.18M | 127.13%170.35M |
| Notes receivable and accounts receivable | 12.80%66.92M | 3.12%59.66M | 15.11%69.39M | 10.25%66.93M | 7.55%59.33M | 6.58%57.86M | 22.71%60.29M | 35.77%60.71M | 26.85%55.17M | 22.02%54.29M |
| -Notes receivable | 189.12%7.07M | -9.25%4.57M | -27.02%3.1M | -2.90%3.2M | -12.19%2.44M | 95.56%5.03M | 108.89%4.25M | 62.31%3.29M | 86.08%2.78M | 89.22%2.57M |
| -Accounts receivable | 5.23%59.86M | 4.30%55.1M | 18.30%66.29M | 11.00%63.74M | 8.59%56.88M | 2.15%52.83M | 18.98%56.04M | 34.50%57.42M | 24.74%52.38M | 19.91%51.71M |
| Other receivables (including interest and dividends) | -40.86%989.89K | -57.93%1.18M | -42.63%1.23M | -47.42%1.31M | -29.36%1.67M | 17.42%2.79M | -47.06%2.15M | -48.44%2.49M | -51.19%2.37M | -44.54%2.38M |
| -Other receivable | ---- | -57.93%1.18M | ---- | -47.42%1.31M | ---- | 17.42%2.79M | ---- | -48.44%2.49M | ---- | -44.54%2.38M |
| Advance payment | -55.80%4.76M | -44.58%7.29M | -56.29%6.43M | -44.32%7.49M | -34.25%10.77M | 1.56%13.15M | -8.55%14.7M | -11.24%13.45M | 21.10%16.38M | 30.79%12.95M |
| Inventories | 1.96%171.13M | 1.17%170.42M | -7.81%163.84M | -5.95%166.54M | -3.00%167.84M | 7.83%168.44M | 21.01%177.72M | 41.23%177.08M | 50.46%173.03M | 54.93%156.21M |
| Other current assets | -20.80%5.69M | -34.77%4.9M | -24.33%5.62M | -17.58%6.45M | -11.60%7.19M | 1.39%7.51M | -29.08%7.43M | -7.61%7.83M | -22.74%8.13M | -7.61%7.41M |
| Total current assets | -1.65%770.6M | -3.79%767.51M | -8.47%714.33M | -6.39%729.74M | 0.91%783.51M | 2.75%797.75M | 3.32%780.41M | 6.11%779.59M | 6.12%776.43M | 5.33%776.42M |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%10M | 0.00%10M | --10M | --10M | --10M | --10M | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | -4.75%140.37M | ---- | 5.50%145.54M | ---- | 6.37%147.37M | ---- | 100.70%137.95M | ---- | 100.30%138.55M |
| Constru in process | ---- | ---- | ---- | -99.18%79.07K | ---- | -67.91%1.04M | ---- | -80.47%9.67M | ---- | -92.09%3.24M |
| Intangible assets | -5.28%21.07M | -4.84%21.38M | 1.66%21.66M | 3.03%21.95M | 35.92%22.25M | 36.09%22.47M | 31.87%21.3M | 33.07%21.3M | 2.24%16.37M | 2.44%16.51M |
| Goodwill | -53.91%7.25M | -53.87%7.25M | -25.88%15.63M | -25.52%15.77M | -23.23%15.73M | -23.96%15.72M | 0.74%21.08M | 4.91%21.17M | 5.18%20.49M | 5.81%20.67M |
| Long deferred expense | -5.77%1.85M | -15.74%1.82M | -26.68%1.65M | -27.14%1.78M | -25.76%1.96M | -24.12%2.16M | -60.62%2.25M | -48.09%2.45M | -45.43%2.64M | -38.13%2.85M |
| Deferred tax assets | -36.94%3.72M | -8.40%4.54M | 42.75%6.86M | 49.12%5.98M | 122.10%5.91M | 75.31%4.96M | 32.01%4.81M | -5.61%4.01M | -25.65%2.66M | -33.25%2.83M |
| Usufruct assets | -11.94%2.54M | -6.46%2.83M | -3.98%2.97M | 690.68%2.71M | 459.12%2.89M | 564.69%3.03M | 423.96%3.09M | -55.70%342.75K | -47.78%516.3K | -34.90%455.97K |
| Other non current assets | --5.51K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current assets | -10.70%184.14M | -8.97%188.2M | -5.31%201.01M | 3.51%203.8M | 11.60%206.2M | 11.69%206.75M | 25.78%212.28M | 19.93%196.89M | 19.09%184.77M | 19.14%185.11M |
| Total assets | -3.53%954.74M | -4.86%955.71M | -7.79%915.34M | -4.40%933.54M | 2.97%989.71M | 4.47%1B | 7.42%992.68M | 8.64%976.48M | 8.39%961.2M | 7.74%961.53M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 34.36%47.95M | -6.36%39.6M | -24.50%30.82M | -7.74%36.93M | -17.03%35.69M | 2.74%42.29M | 57.08%40.83M | 98.27%40.03M | 79.38%43.01M | 71.95%41.16M |
| -Accounts payable | 34.36%47.95M | -6.36%39.6M | -24.50%30.82M | -7.74%36.93M | -17.03%35.69M | 2.74%42.29M | 57.08%40.83M | 98.27%40.03M | 79.38%43.01M | 71.95%41.16M |
| Contract liabilities | -30.36%42.27M | -16.08%62.49M | -39.52%39.16M | -14.76%47.85M | 29.94%60.69M | 30.91%74.47M | 32.00%64.74M | 69.27%56.14M | 34.95%46.7M | 29.60%56.88M |
| Salaries payable | 1.34%16.52M | -4.84%14.42M | -50.04%6.27M | -59.44%4.14M | 5.09%16.3M | -1.94%15.16M | 65.63%12.56M | 74.06%10.21M | 16.64%15.51M | 4.24%15.46M |
| Taxs payable | 36.40%2M | 52.63%4.53M | -6.65%2.97M | 16.10%2.87M | -45.87%1.47M | -32.66%2.97M | -59.12%3.18M | -51.86%2.47M | -15.63%2.72M | -18.28%4.41M |
| Other payable (including interest and dividends) | -17.19%7.36M | -16.23%7.7M | 62.71%16.37M | 53.93%21.21M | 44.38%8.89M | 24.07%9.19M | 67.02%10.06M | -51.89%13.78M | 30.70%6.16M | -24.28%7.41M |
| -Dividend payable | ---- | ---- | 171.07%7.99M | 47.23%11.6M | ---- | ---- | --2.95M | -66.49%7.88M | ---- | ---- |
| -Other payable | ---- | -16.23%7.7M | ---- | 62.88%9.6M | ---- | 24.07%9.19M | ---- | 15.19%5.9M | ---- | -24.28%7.41M |
| Non current liabilities due within one year | 79.72%1.05M | 61.47%1.06M | 50.23%1.03M | 462.21%737.98K | 138.82%586.8K | 121.80%659.4K | 111.80%684.5K | -81.25%131.26K | 3.76%245.71K | -17.19%297.29K |
| Other current liabilities | -33.43%3.07M | 6.00%3.85M | -4.33%4.46M | 0.51%4.55M | 30.09%4.61M | -22.52%3.63M | 22.42%4.66M | 20.67%4.53M | -5.00%3.54M | 37.82%4.69M |
| Total current liabilities | -6.25%120.22M | -9.91%133.66M | -26.06%101.09M | -7.07%118.3M | 8.78%128.23M | 13.86%148.37M | 35.95%136.72M | 30.63%127.29M | 40.71%117.88M | 28.25%130.31M |
| Current liabilities | ||||||||||
| Long term salaries pay | -6.41%206.85K | 4.13%220.79K | -50.01%245.59K | -63.44%159.41K | -62.36%221.03K | -54.22%212.04K | -30.78%491.31K | -45.42%436.05K | -35.30%587.15K | -53.14%463.2K |
| Deferred tax liabilities | -36.21%1.18M | -1.22%1.21M | -8.60%1.18M | -7.69%1.22M | 37.09%1.85M | -12.02%1.22M | 111.06%1.29M | 128.87%1.32M | 147.05%1.35M | 153.77%1.39M |
| Long term deferred income | -96.18%145.65K | -92.69%163.12K | -91.98%180.6K | 67.47%3.8M | 66.95%3.82M | -3.03%2.23M | -3.01%2.25M | -2.99%2.27M | -10.49%2.29M | -10.42%2.3M |
| Lease liabilities | -32.85%1.51M | -20.66%1.8M | -17.43%1.93M | 1,325.50%1.97M | 1,156.37%2.26M | 6,440.11%2.27M | 1,504.84%2.33M | 344.03%138.15K | -74.23%179.49K | -85.42%34.76K |
| Other non current liabilities | 38.72%1.2M | 23.18%1.07M | 129.95%1.27M | 142.58%1.18M | 19.81%864.65K | 143.99%867K | 165.83%551.91K | 147.32%484.95K | 10,547.22%721.67K | 249.59%355.34K |
| Total non current liabilities | -52.86%4.24M | -34.44%4.46M | -30.59%4.8M | 79.07%8.32M | 75.81%9M | 49.75%6.81M | 73.18%6.92M | 17.93%4.65M | 8.74%5.12M | 2.24%4.55M |
| Total liabilities | -9.30%124.46M | -10.99%138.12M | -26.28%105.89M | -4.03%126.62M | 11.57%137.23M | 15.07%155.17M | 37.38%143.63M | 30.13%131.94M | 39.01%123M | 27.16%134.85M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.32%67.45M | 0.32%67.45M | 0.00%67.24M | 0.00%67.24M | 0.00%67.24M | 0.00%67.24M | 0.06%67.24M | 0.06%67.24M | 0.35%67.24M | 0.35%67.24M |
| Capital reserve funds | 0.71%413.92M | 0.96%413.51M | 1.44%413.94M | 1.47%412.48M | 1.49%411.03M | 1.51%409.57M | 0.98%408.05M | 0.83%406.52M | 1.60%405M | 1.46%403.47M |
| Surplus reserve funds | 0.32%33.73M | 0.32%33.73M | 0.00%33.62M | 0.00%33.62M | 0.00%33.62M | 0.00%33.62M | 8.19%33.62M | 3.36%33.62M | 8.19%33.62M | 8.19%33.62M |
| Retained profit | -6.18%319.22M | -6.76%306.45M | -7.70%302.51M | -7.62%299.24M | 3.92%340.24M | 4.49%328.66M | 6.77%327.76M | 10.51%323.93M | 6.34%327.41M | 6.27%314.55M |
| Less:Treasury stock | 70.13%17.01M | --17.01M | --17.01M | --17.01M | --10M | ---- | ---- | ---- | ---- | ---- |
| Other composite income | 25.17%12.97M | 31.45%13.46M | -26.02%9.16M | -14.19%11.36M | 109.92%10.36M | 31.16%10.24M | 21.90%12.39M | 804.03%13.24M | 178.80%4.94M | 247.01%7.8M |
| Shareholders equity without minority interests | -2.60%830.28M | -3.74%817.59M | -4.66%809.45M | -4.45%806.92M | 1.70%852.48M | 2.74%849.32M | 3.60%849.05M | 5.90%844.54M | 5.00%838.2M | 5.12%826.68M |
| Total shareholder equity | -2.60%830.28M | -3.74%817.59M | -4.66%809.45M | -4.45%806.92M | 1.70%852.48M | 2.74%849.32M | 3.60%849.05M | 5.90%844.54M | 5.00%838.2M | 5.12%826.68M |
| Total liabilityies and equity | -3.53%954.74M | -4.86%955.71M | -7.79%915.34M | -4.40%933.54M | 2.97%989.71M | 4.47%1B | 7.42%992.68M | 8.64%976.48M | 8.39%961.2M | 7.74%961.53M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs